Sagimet Biosciences Files 8-K for Material Agreement
Ticker: SGMT · Form: 8-K · Filed: Apr 28, 2026 · CIK: 0001400118
| Field | Detail |
|---|---|
| Company | Sagimet Biosciences Inc. (SGMT) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
TL;DR
Sagimet just signed a big deal, filing an 8-K to make it official.
AI Summary
Sagimet Biosciences Inc. filed an 8-K on April 28, 2026, to report the entry into a material definitive agreement. The filing includes exhibits such as the 8-K document itself, an agreement (EX-1.1), and legal opinions (EX-5.1).
Why It Matters
This filing indicates a significant new contract or partnership for Sagimet Biosciences, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing itself is procedural, but the nature of the 'material definitive agreement' could carry significant risks or rewards for the company.
Key Players & Entities
- Sagimet Biosciences Inc. (company) — Filer of the 8-K
- 0001400118 (company) — CIK number for Sagimet Biosciences Inc.
- 2026-04-28 (date) — Filing date of the 8-K
- 2026-04-27 (date) — Period of report for the 8-K
FAQ
What is the nature of the material definitive agreement entered into by Sagimet Biosciences?
The filing does not specify the exact nature of the agreement, but it is listed under Item 1.01, indicating a significant definitive agreement.
When was this 8-K filing accepted by the SEC?
The 8-K filing was accepted on April 28, 2026, at 07:01:04.
What are the key exhibits included with this 8-K filing?
Key exhibits include the 8-K document itself (FORM 8-K), an agreement labeled EXHIBIT 1.1, and legal opinions labeled EXHIBIT 5.1.
What is the business address of Sagimet Biosciences?
The business address of Sagimet Biosciences is 155 BOVET RD., SUITE 303, SAN MATEO CA 94402.
What SIC code is associated with Sagimet Biosciences?
Sagimet Biosciences is associated with SIC code 2834, which pertains to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2026 regarding Sagimet Biosciences Inc. (SGMT).